Yahoo Finance

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 ...

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) Drugs in Development by Therapy ...
Yahoo Finance

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications ...

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 ...
Nature

Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches

Highly active anti-retroviral therapy (HAART) is the standard of care for HIV infection; however, pharmacogenomic approaches highlighted significant interindividual differences in drug disposition, ...
Science Daily

Alcohol Worse Than Ecstasy, According To Proposed 'Matrix Of Harm' For Drugs

A new study proposes that drugs should be classified by the amount of harm that they do. The new ranking places alcohol and tobacco in the upper half of the league table. These socially accepted drugs ...
EurekAlert!

A new 'matrix of harm' for drugs of abuse

A new study published today in the Lancet proposes that drugs should be classified by the amount of harm that they do, rather than the sharp A, B, and C divisions in the UK Misuse of Drugs Act. The ...